Valuation: IXICO plc

Market Cap 16.35M 22.09M 19.14M 17.93M 30.75M 2.11B 31.22M 211M 82.43M 1.05B 82.93M 81.13M 3.52B P/E 2026 *
-5.36x
P/E 2027 * -5.77x
Enterprise Value 6.15M 8.31M 7.2M 6.75M 11.57M 793M 11.75M 79.35M 31.02M 397M 31.2M 30.53M 1.32B EV / Sales 2026 *
0.77x
EV / Sales 2027 * 1.14x
Free-Float
89.22%
Yield 2026 *
-
Yield 2027 * -
1 day+3.45%
1 week-6.25%
Current month-6.25%
1 month-18.92%
3 months+11.11%
6 months-14.29%
Current year-36.17%
1 week 7
Extreme 7
8.5
1 month 7
Extreme 7
9
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
21
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-18
Director of Finance/CFO 50 2019-08-20
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 2019-08-20
Director/Board Member 60 2022-01-20
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Buy

Chairman

50,006 0.0228%
6/13/25 Free 350,000 0.3777%
6/13/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
+3.45%-6.25%-38.78%-63.05% 21.36M
-1.60%+0.86%+3.70%+14.41% 49.54B
-0.14%+4.03%+482.13%+584.43% 44.06B
-0.06%+9.62%+24.63%+81.63% 40.85B
-0.87%+2.40%+30.01%+9.95% 40.14B
-4.04%+6.15%+23.03%+48.00% 34.17B
-1.41%+1.57%+29.98%+123.68% 16.9B
+0.35%+4.61% - - 16.78B
-0.43%-0.11%+4.22%+20.83% 14B
+0.84%+9.07%+86.17%+32.60% 13.46B
Average -0.39%+3.64%+71.68%+94.72% 26.99B
Weighted average by Cap. -1.01%+5.04%+103.29%+136.90%

Financials

2026 *2027 *
Net sales 8M 10.8M 9.36M 8.77M 15.04M 1.03B 15.27M 103M 40.32M 516M 40.57M 39.69M 1.72B 9M 12.16M 10.53M 9.87M 16.92M 1.16B 17.18M 116M 45.36M 581M 45.64M 44.65M 1.94B
Net income -2.14M -2.89M -2.51M -2.35M -4.03M -276M -4.09M -27.63M -10.8M -138M -10.87M -10.63M -461M -2.8M -3.78M -3.28M -3.07M -5.27M -361M -5.35M -36.12M -14.12M -181M -14.2M -13.89M -602M
Net Debt -10.2M -13.78M -11.94M -11.18M -19.18M -1.31B -19.47M -132M -51.41M -658M -51.72M -50.6M -2.19B -6.1M -8.24M -7.14M -6.69M -11.47M -786M -11.64M -78.66M -30.75M -393M -30.93M -30.26M -1.31B
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26-08-12 GBX 7.500 +3.45% 258
26-08-11 GBX 7.250 -9.38% 134,025
26-08-10 GBX 8.000 0.00% 131
26-08-07 GBX 8.000 0.00% 10,000
26-08-06 GBX 8.000 0.00% 42,600
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750GBP
Average target price
0.2600GBP
Spread / Average Target
+246.67%

Annual profits - Rate of surprise